Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ricki T Krog

4PUBLICATIONS

13CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jan 11, 2024

Author Correction: Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells.

Julie Zimmermann, Simon D van Haren, Joann Diray-Arce

|Dec 22, 2023

Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells.

Julie Zimmermann, Simon D van Haren, Joann Diray-Arce

|Mar 17, 2022

Tertiary lymphoid structures critical for prognosis in endometrial cancer patients.

Nanda Horeweg, Hagma H Workel, Dominik Loiero

|Nov 27, 2021

The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma.

Ricki T Krog, Noel F C C de Miranda, Alexander L Vahrmeijer

Pageof 1

Frequent Collaborators

2 joint publications

Gabriel K Pedersen

2 joint publications

Dennis Christensen

2 joint publications

Julie Zimmermann

2 joint publications

Simon D van Haren

2 joint publications

Katharina Wørzner

2 joint publications

Rasmus Mortensen

2 joint publications

Jes Dietrich

2 joint publications

Ofer Levy

1 joint publications

Nanda Horeweg

1 joint publications

Dominik Loiero

Frequent Collaborators

2 joint publications

Gabriel K Pedersen

2 joint publications

Dennis Christensen

2 joint publications

Julie Zimmermann

2 joint publications

Simon D van Haren

Top Related Videos

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells <em>In Vitro</em> and <em>In Vivo</em>

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells <em>In Vitro</em> and <em>In Vivo</em>

Published on : Feb 05, 2021

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on : Feb 28, 2019

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8<sup>+</sup> T Cells During Tumorigenesis

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8<sup>+</sup> T Cells During Tumorigenesis

Published on : Jan 26, 2024

See more related videos

Top Related Videos

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells <em>In Vitro</em> and <em>In Vivo</em>

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells <em>In Vitro</em> and <em>In Vivo</em>

Published on : Feb 05, 2021

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on : Feb 28, 2019

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8<sup>+</sup> T Cells During Tumorigenesis

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8<sup>+</sup> T Cells During Tumorigenesis

Published on : Jan 26, 2024

See more related videos